[1]
|
V. K. Jain, R. V. Cestero and J. Baum, “Carpal Tunnel Syndrome in Patients Undergoing Maintenance Hemodialysis,” Journal of the American Veterinary Medical Association, Vol. 242, No. 26, 1979, pp. 2868-2869. doi:10.1001/jama.242.26.2868
|
[2]
|
H. G. Kachel, P. Altmeyer, C. A. Baldamus and K. Koch, “Deposition of an Amyloid-like Substance as a Possible Complication of Regular Dialysis Treatment,” Contributions to Nephrology, Vol. 36, 1983, pp. 127-132.
|
[3]
|
W. R. Brian and A. D. Wright, “Spontaneous Compression of Both Median Nerves in the Carpal Tunnel,” Lancet, Vol. 1, 1947, pp. 277-282.
|
[4]
|
E. Viikari-Juntura and B. Silverstein, “Role of Physical Load Factors in Carpal Tunnel Syndrome,” Scandinavian Journal of Work, Environment & Health, Vol. 25, No. 5, 1999, pp. 163-185.
|
[5]
|
T. Bardin, J. Zingraff, D. Kuntz and T. Drueke, “Dialsis-related Amyloidosis,” Nephrol Dial Transplant, Vol. 1, No. 3, 1986, pp.151-154.
|
[6]
|
E. A. Brown, I. R. Arnold and P. E. Gower, “Dialysis Arthropathy: A Complication of Long-term Treatment with Haemodialysis,” British Medical Journal, Vol. 292, No. 6514, 1986, pp. 163-166.
|
[7]
|
Y. Shimizu, A. Van Sevevter, K. J. Horgan and S. Shaw, “Regulated Expression and Binding of Three VLA (beta 1) Integrin Receptors on Tcells,” Nature, Vol. 345, No. 6272, 1990, pp.250-253. doi:10.1038/345250a0
|
[8]
|
G. S. Phalen, “Reflections on 21 Years Experience with the Carpal-tunnel Syndrome,” Journal of the American Medical Association, Vol. 212, No. 8, 1970, pp.1365- 1367.
|
[9]
|
G. S. Phalen, “The Carpal-tunnel Syndrome. Clinical Evaluation of 598 Hands,” Clinical Orthopaedics and Related Research, Vol. 83, 1972, pp.29-40.
doi:10.1097/00003086-197203000-00007
|
[10]
|
I. Kimura and D. R. Ayyar, “The Carpal Tunnel Syndrome: Electrophysiological Aspects of 639 Symptomatic Extremities,” Electromyography & Clinical Neurophysiology, Vol. 25, No. 2-3, 1985, pp. 151- 164.
|
[11]
|
J. Chanard, S. Lavaud, O. Toupance, H. Roujouleh and J. P. Melin, “Carpal Tunnel Syndrome and Type of Dialysis Membrane Used in Patients Undergoing Long-term Hemodialysis,” Arthritis Rheum, Vol. 29, No. 9, 1986, pp. 1170-1171. doi:10.1002/art.1780290919
|
[12]
|
R. F. Gagnon, P. Somerville and M. Kaye, “β2-micro- globulin Serum Levels in Patients on Long-term Dialysis,” Perit Dial Bull, Vol. 7, No. 6, 1987, pp. 29-31.
|
[13]
|
L. H. Connors, T. Shirahama, M. Skinner, A. Fenves and A. S. Cohen, “In Vitro Formation of Amyloid Fibrils from Intact β2-microglobulin,” Biochemical and Biophysical Research Communications, Vol. 131, No. 3, 1985, pp. 1063-1068.
doi:10.1016/0006-291X(85)90198-6
|
[14]
|
N. Miyasaka, K. Sato, Y. Kitano, M. Higaki, K. Nishioka and K. Ohta, “Aberrant Cytokine Production from Tenosynovium in Dialysis Associated Amyloidosis,” Annals of the Rheumatic Diseases, Vol. 51, No. 6, 1992, pp.797-802.
|
[15]
|
J. A. Delmez, B. Holtmann, G. A. Sicard, A. P. Goldberg and H. R. Harter, “Peripheral Nerve Entrapment Syndromes in Chronic Hemodialysis Patients,” Nephron, Vol. 30, No. 2, 1982, pp.118-123. doi:10.1159/000182447
|
[16]
|
J. A. Bussell, J. A. Abbot and R. C. Lim, “A Radial Steal Syndrome with Arteriovenous Fistula for Hemodialysis. Studies in Seven Patients,” Annals of Internal Medicine, Vol. 75, No. 3, 1971, pp.387-394.
|